<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05612386</url>
  </required_header>
  <id_info>
    <org_study_id>851911-Trial E</org_study_id>
    <nct_id>NCT05612386</nct_id>
  </id_info>
  <brief_title>Planning Message Recommending Same Time/Location as Last Vaccine</brief_title>
  <official_title>Planning Message Recommending Same Time/Location as Last Vaccine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This experiment is part of a megastudy with a total of ten experimental conditions and a&#xD;
      holdout control condition to which patients will be randomly assigned. The focal comparison&#xD;
      in this experiment is between a message suggesting the same day of the week, at the same time&#xD;
      of day, and at the same pharmacy location as their last vaccination and a control message&#xD;
      telling patients that an updated COVID booster vaccine is waiting for them. The intervention&#xD;
      testing if text messages encouraging vaccination by suggesting patients receive a shot on the&#xD;
      same day of the week, at the same time of day, and at the same pharmacy location as their&#xD;
      last vaccination will produce more vaccinations than otherwise identical messages.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 3, 2022</start_date>
  <completion_date type="Actual">February 6, 2023</completion_date>
  <primary_completion_date type="Actual">December 8, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomly assigned to the different arms.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
    <masking_description>As treated participants will receive text messages, there is no scope for blinding. Care providers will not be made aware of subjects' participation in the study, or assigned treatment arms. The study team will only receive data on subjects' assigned arms and outcomes at the end of the study.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>COVID bivalent booster receipt</measure>
    <time_frame>During the 30 days after receiving the SMS/MMS intervention</time_frame>
    <description>Whether patients receive a bivalent COVID booster at the pharmacy in question</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>COVID bivalent booster receipt</measure>
    <time_frame>60 days after receiving the SMS/MMS intervention</time_frame>
    <description>Whether patients receive a bivalent COVID booster at the pharmacy in question</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>COVID bivalent booster receipt</measure>
    <time_frame>90 days after receiving the SMS/MMS intervention</time_frame>
    <description>Whether patients receive a bivalent COVID booster at the pharmacy in question</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">520000</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Control condition with &quot;waiting for you&quot; message</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This control condition will use the text message that the investigators found to be the best performing in their last mega-study of vaccine text messages to recommend a COVID vaccination.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Planning message recommending same time/location as last vaccination</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This condition will use a text message recommending the same time and location as the participant's last vaccination to get a COVID vaccination.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>COVID Booster text messages</intervention_name>
    <description>Participants will receive text messages per descriptions listed in the arms.</description>
    <arm_group_label>Control condition with &quot;waiting for you&quot; message</arm_group_label>
    <arm_group_label>Planning message recommending same time/location as last vaccination</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Exclusion Criteria:&#xD;
&#xD;
          1. The patient unsubscribed from texts before the send date and time of the patient's&#xD;
             SMS/MMS message&#xD;
&#xD;
          2. The patient received a bivalent COVID booster before the send date and time of the&#xD;
             patient's SMS/MMS message.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>November 3, 2022</study_first_submitted>
  <study_first_submitted_qc>November 3, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2022</study_first_posted>
  <last_update_submitted>March 1, 2023</last_update_submitted>
  <last_update_submitted_qc>March 1, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>behavioral science interventions</keyword>
  <keyword>vaccination promotion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

